PMID: 2491597Jan 1, 1989Paper

Analyses on possible heterogeneity of IDDM based on presence of islet cell cytoplasmic antibody at diagnosis

Autoimmunity
D E CavenderA L Drash

Abstract

In a large, representative sample of newly-diagnosed IDDM patients, using a highly sensitive assay to detect islet cell cytoplasmic antibodies (ICA), no marked differences were found between ICA+ and ICA- patients on various clinical, genetic, immunologic, and epidemiologic characteristics. In particular, there was no evidence for associations between ICA status at diagnosis and either sex, race, family history of IDDM, HLA-DR phenotype, antibody titers to Coxsackie B viruses, immunoglobulin levels, C-peptide and glycosylated hemoglobin concentrations, or insulin requirements. The most significant relationship was between the presence of ICA and a young age at diagnosis; however, the large overlap between the distributions of the ages at onset for ICA+ and ICA- groups on this variable suggests that this association is of limited importance. These data suggest that the presence or absence of ICA at diagnosis may not be useful in defining possible subtypes of IDDM.

References

Sep 25, 1976·Lancet·P J MorrisJ W Farquhar
Dec 11, 1976·Lancet·R LendrumD R Gamble
Jul 15, 1978·British Medical Journal·G F BottazzoD Doniach
Nov 4, 1978·British Medical Journal·G F BottazzoH Festenstein
Aug 1, 1979·Metabolism: Clinical and Experimental·H LudwigW R Mayr
Mar 6, 1976·British Medical Journal·R LendrumD R Gamble
Jun 26, 1976·British Medical Journal·R LendrumD R Gamble
Sep 1, 1974·Human Pathology·W HenleC A Horwitz
Jan 1, 1982·The Journal of Pediatrics·G M BrightW L Clarke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.